Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients

Clin Diagn Lab Immunol. 1999 Mar;6(2):279-81. doi: 10.1128/CDLI.6.2.279-281.1999.

Abstract

An enzyme immunoassay based on three synthetic peptides from the core, NS4, and NS5 regions of hepatitis C virus allowed the detection of antibodies in 100% of immunocompetent infected patients and in 91% of immunocompromised patients (hemodialysis and hemophiliac patients). Immune impairment seemed to restrict the spectrum of antibody isotypes reacting to the core peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Viral / blood*
  • DNA, Viral / analysis
  • Hemophilia A / immunology
  • Hemophilia A / virology
  • Hepacivirus / chemistry
  • Hepacivirus / immunology*
  • Hepatitis C / immunology*
  • Humans
  • Immunocompromised Host / immunology*
  • Immunoenzyme Techniques
  • Kidney Failure, Chronic / immunology
  • Kidney Failure, Chronic / therapy
  • Kidney Failure, Chronic / virology
  • Molecular Sequence Data
  • Renal Dialysis
  • Viral Nonstructural Proteins / analysis
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / immunology

Substances

  • Antibodies, Viral
  • DNA, Viral
  • NS4 protein, hepatitis C virus
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus